» Articles » PMID: 29108370

Prevalence of Malnutrition in Patients at First Medical Oncology Visit: the PreMiO Study

Abstract

Background: In cancer patients, malnutrition is associated with treatment toxicity, complications, reduced physical functioning, and decreased survival. The Prevalence of Malnutrition in Oncology (PreMiO) study identified malnutrition or its risk among cancer patients making their first medical oncology visit. Innovatively, oncologists, not nutritionists, evaluated the nutritional status of the patients in this study.

Methods: PreMiO was a prospective, observational study conducted at 22 medical oncology centers across Italy. For inclusion, adult patients (>18 years) had a solid tumor diagnosis, were treatment-naive, and had a life expectancy >3 months. Malnutrition was identified by the Mini Nutritional Assessment (MNA), appetite status with a visual analog scale (VAS), and appetite loss with a modified version of Anorexia-Cachexia Subscale (AC/S-12) of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT).

Findings: Of patients enrolled (1,952), 51% had nutritional impairment; 9% were overtly malnourished, and 43% were at risk for malnutrition. Severity of malnutrition was positively correlated with the stage of cancer. Over 40% of patients were experiencing anorexia, as reported in the VAS and FAACT questionnaire. During the prior six months, 64% of patients lost weight (1-10 kg).

Interpretation: Malnutrition, anorexia, and weight loss are common in cancer patients, even at their first visit to a medical oncology center.

Citing Articles

Identifying Nutritional Inequities of Patients with Cancer Residing in Food Deserts.

LePore L, Kronfli D, Baker K, Eggleston C, Schotz K, Kleckner A Adv Radiat Oncol. 2025; 10(1):101641.

PMID: 40017914 PMC: 11867131. DOI: 10.1016/j.adro.2024.101641.


Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study.

Del Olmo-Garcia M, Hernandez-Rienda L, Garcia-Carbonero R, Hernando J, Custodio A, Anton-Pascual B Oncologist. 2025; 30(2).

PMID: 39998905 PMC: 11853595. DOI: 10.1093/oncolo/oyae343.


Malnutrition and sarcopenia in inpatient rehabilitation: prevalence and associations with changes in bodyweight, muscle strength, and functional independence.

Lehmann U, Uhlmann K, Meichtry A, Spielmanns M, Spielmanns S, Khatami R J Rehabil Med. 2025; 57:jrm42215.

PMID: 39998491 PMC: 11877858. DOI: 10.2340/jrm.v57.42215.


VARIATIONS IN DIETARY HABITS DURING CANCER TREATMENT: RESULTS OF A CROSS-SECTIONAL SURVEY.

Ennouri S, Daoud N, Berrazegua Y, El Benna H, Korbi S, Rachdi H Acta Clin Croat. 2025; 63(1):80-88.

PMID: 39959318 PMC: 11827403. DOI: 10.20471/acc.2024.63.01.10.


Nutritional Status and Information Provided to Polish Cancer Patients Assessed Using the EORTC QLQ-INFO25 Questionnaire.

Gliwska E, Glabska D, Zaczek Z, Sobocki J, Guzek D J Clin Med. 2025; 14(3).

PMID: 39941366 PMC: 11818191. DOI: 10.3390/jcm14030697.


References
1.
Attar A, Malka D, Sabate J, Bonnetain F, Lecomte T, Aparicio T . Malnutrition is high and underestimated during chemotherapy in gastrointestinal cancer: an AGEO prospective cross-sectional multicenter study. Nutr Cancer. 2012; 64(4):535-42. DOI: 10.1080/01635581.2012.670743. View

2.
Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff S . ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2016; 36(1):49-64. DOI: 10.1016/j.clnu.2016.09.004. View

3.
Argiles J, Muscaritoli M . Unifying diagnostic criteria for cachexia: An urgent need. Clin Nutr. 2017; 36(3):910-911. DOI: 10.1016/j.clnu.2017.01.020. View

4.
Maasberg S, Knappe-Drzikova B, Vonderbeck D, Jann H, Weylandt K, Grieser C . Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia. Neuroendocrinology. 2015; 104(1):11-25. DOI: 10.1159/000442983. View

5.
Laviano A, Koverech A, Mari A . Cachexia: clinical features when inflammation drives malnutrition. Proc Nutr Soc. 2015; 74(4):348-54. DOI: 10.1017/S0029665115000117. View